Clay B. Siegall - Insider Trading & Ownership

Entity
Individual
Location
21823 30 Th Dr Se, Bothell, Washington
Summary
The estimated net worth of Clay B. Siegall is at least $158M dollars as of August 13, 2024. Clay B. Siegall is the President & CEO, Director of Seagen Inc. and owns shares of Seagen Inc. stock worth about $153M. Clay B. Siegall is the President and CEO, Director of Immunome Inc. and owns shares of Immunome Inc. (IMNM) stock worth about $5.78M.
All Insider Reports
All Insider Reports

Ownership of Clay B. Siegall

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SGEN Seagen Inc. President & CEO, Director $153M May 12, 2022
IMNM Immunome Inc. President and CEO, Director $5.78M +$2.39M +70.4% Aug 9, 2024
NRIX Nurix Therapeutics, Inc. Director May 5, 2022
STTK Shattuck Labs, Inc. Director Jun 21, 2024
TRML Tourmaline Bio, Inc. Director Jun 5, 2024

Insider Transactions Reported by Clay B. Siegall:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.